$Gyre Therapeutics (GYRE.US)$ GYRE The turnover is still to...
$Gyre Therapeutics (GYRE.US)$ GYRE
The turnover is still too low.
Well, while I'm talking about that too,
Things are going to change all at once along with stock prices.
It's not a one-off rate of change around 20-30%.
What would happen to the appropriate market capitalization for both parent companies' GNI?
The turnover is still too low.
Well, while I'm talking about that too,
Things are going to change all at once along with stock prices.
It's not a one-off rate of change around 20-30%.
What would happen to the appropriate market capitalization for both parent companies' GNI?
As I've said many times,
I still don't plan on selling them as platinum tickets.
Short-term immediate 45-75, medium term 150, long term...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
米国株はGYRE、日本株はGNIをメイン。
NPCは第二の野村マイクロ銘柄かな。
APDNのサル痘🚀に期待。
PULMは静観でin待ち中。
81Followers
4Following
362Visitors
Follow